Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:MBAI NYSE:MLSS NYSE:NSPR NASDAQ:TELA On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeMBAICheck-Cap$1.14$1.52$0.59▼$3.92$8.31M0.6573,522 shs51,733 shsMLSSMilestone Scientific$0.34$0.36$0.22▼$0.73$30.28M1.041.17 million shs145,556 shsNSPRInspireMD$0.70$0.94$0.63▼$2.93$32.74M0.74175,419 shs160,103 shsTELATELA Bio$0.72$0.86$0.50▼$2.20$32.29M1.34111,739 shs14,475 shs5G Stocks: The Path Forward is ProfitableClick the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceMBAICheck-Cap-8.06%+2.70%-31.74%-37.36%+113,999,900.00%MLSSMilestone Scientific-2.34%+6.30%-12.68%+20.49%-45.33%NSPRInspireMD+2.42%+6.72%-30.79%-54.61%-68.65%TELATELA Bio+0.19%-2.51%-20.73%+20.78%-62.23%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeMBAICheck-Cap$1.14$1.52$0.59▼$3.92$8.31M0.6573,522 shs51,733 shsMLSSMilestone Scientific$0.34$0.36$0.22▼$0.73$30.28M1.041.17 million shs145,556 shsNSPRInspireMD$0.70$0.94$0.63▼$2.93$32.74M0.74175,419 shs160,103 shsTELATELA Bio$0.72$0.86$0.50▼$2.20$32.29M1.34111,739 shs14,475 shs5G Stocks: The Path Forward is ProfitableClick the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceMBAICheck-Cap-8.06%+2.70%-31.74%-37.36%+113,999,900.00%MLSSMilestone Scientific-2.34%+6.30%-12.68%+20.49%-45.33%NSPRInspireMD+2.42%+6.72%-30.79%-54.61%-68.65%TELATELA Bio+0.19%-2.51%-20.73%+20.78%-62.23%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceMBAICheck-Cap 1.00SellN/AN/AMLSSMilestone Scientific 3.00Buy$1.00192.14% UpsideNSPRInspireMD 3.00Buy$4.50543.78% UpsideTELATELA Bio 2.40Hold$2.20204.96% UpsideCurrent Analyst Ratings BreakdownLatest MBAI, TELA, NSPR, and MLSS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/5/2026NSPRInspireMD Piper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOverweight$4.00 ➝ $3.005/4/2026NSPRInspireMD Lake Street CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$4.004/24/2026MBAICheck-Cap Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)4/21/2026TELATELA Bio Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)(Data available from 7/3/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookMBAICheck-CapN/AN/A$0.52 per share2.18$0.47 per shareN/AMLSSMilestone Scientific$8.90M3.40N/AN/A$0.11 per share3.11NSPRInspireMD$10.85M3.02N/AN/A$1.83 per share0.38TELATELA Bio$80.81M0.40N/AN/A$0.16 per share4.51Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateMBAICheck-Cap$4.14M-$2.77N/AN/AN/AN/AN/AN/AN/AMLSSMilestone Scientific-$6.93M-$0.05N/AN/AN/A-52.01%-60.26%-40.23%N/ANSPRInspireMD-$19.92M-$0.73N/AN/AN/A-413.96%-69.42%-57.68%N/ATELATELA Bio-$38.83M-$0.79N/AN/AN/A-49.30%-1,320.81%-55.83%8/10/2026 (Estimated)Latest MBAI, TELA, NSPR, and MLSS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/12/2026Q1 2026TELATELA Bio-$0.14-$0.21-$0.07-$0.21$18.60 million$19.06 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthMBAICheck-CapN/AN/AN/AN/AN/AMLSSMilestone ScientificN/AN/AN/AN/AN/ANSPRInspireMDN/AN/AN/AN/AN/ATELATELA BioN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioMBAICheck-CapN/A0.050.05MLSSMilestone ScientificN/A2.851.86NSPRInspireMDN/A6.396.05TELATELA Bio8.823.612.92Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipMBAICheck-Cap1.07%MLSSMilestone Scientific5.79%NSPRInspireMD44.78%TELATELA Bio94.35%Insider OwnershipCompanyInsider OwnershipMBAICheck-Cap0.48%MLSSMilestone Scientific9.22%NSPRInspireMD29.72%TELATELA Bio5.10%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableMBAICheck-Cap807.29 million7.25 millionN/AMLSSMilestone Scientific3088.45 million58.61 millionOptionableNSPRInspireMD5046.84 million18.33 millionOptionableTELATELA Bio12044.77 million42.48 millionOptionableMBAI, TELA, NSPR, and MLSS HeadlinesRecent News About These CompaniesTELA Bio Healthcare Story Faces New Market ScrutinyMay 15, 2026 | kalkinemedia.comKEarnings Release: Here's Why Analysts Cut Their TELA Bio, Inc. (NASDAQ:TELA) Price Target To US$2.25May 15, 2026 | finance.yahoo.comTELA Bio Inc (TELA) Q1 2026 Earnings Call Highlights: Strong European Growth and Strategic U.S. ...May 13, 2026 | finance.yahoo.comTELA Bio, Inc. (TELA) Q1 2026 Earnings Call TranscriptMay 12, 2026 | seekingalpha.comTELA Bio, Inc. (TELA) Reports Q1 Loss, Beats Revenue EstimatesMay 12, 2026 | zacks.comTELA Bio Reports First Quarter 2026 Financial ResultsMay 12, 2026 | globenewswire.comWhat To Expect From TELA Bio Inc (TELA) Q1 2026 EarningsMay 11, 2026 | finance.yahoo.comTELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)May 7, 2026 | globenewswire.comAxos, Gallagher and TELA Bio post strong growth and strategic movesMay 1, 2026 | msn.comTELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports ...April 30, 2026 | markets.businessinsider.comTELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 RevenuesApril 30, 2026 | globenewswire.comTELA Bio (TELA) Gets a Buy from Canaccord GenuityApril 26, 2026 | theglobeandmail.comTELA Bio to Announce First Quarter 2026 Financial ResultsApril 21, 2026 | globenewswire.comTELA Bio (TELA) price target decreased by 34.78% to 2.30April 10, 2026 | msn.comTELA Bio, Inc. Q4 2025 Earnings Call SummaryMarch 26, 2026 | finance.yahoo.comTELA Bio, Inc.: TELA Bio Reports Fourth Quarter and Full Year 2025 Financial ResultsMarch 26, 2026 | finanznachrichten.deTELA Bio (TELA) Q4 2025 Earnings Call TranscriptMarch 26, 2026 | finance.yahoo.comTELA Bio Q4 Earnings Call HighlightsMarch 26, 2026 | defenseworld.netDTELA Bio Analysts Cut Their Forecasts After Q4 ResultsMarch 25, 2026 | benzinga.comTELA Bio, Inc. (NASDAQ:TELA) Q4 2025 Earnings Call TranscriptMarch 25, 2026 | insidermonkey.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesMission Control: Floating In SpaceX's Record-Breaking OrbitBy Jeffrey Neal Johnson | June 15, 2026SpaceX Rings the Bell and Shatters Every RecordBy Jeffrey Neal Johnson | June 12, 2026Gravity Check: Houston, SpaceX Has a Valuation ProblemBy Jeffrey Neal Johnson | June 16, 2026These 5 Companies Just Made a Massive Bet on ThemselvesBy Thomas Hughes | June 15, 20263 Non-Pharma Firms That Could Benefit From the GLP-1 TrendBy Nathan Reiff | June 20, 2026MBAI, TELA, NSPR, and MLSS Company DescriptionsCheck-Cap NASDAQ:MBAI$1.14 0.00 (0.00%) Closing price 07/2/2026 04:00 PM EasternExtended Trading$1.14 0.00 (0.00%) As of 07/2/2026 07:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.Milestone Scientific NYSE:MLSS$0.34 0.00 (0.00%) Closing price 07/2/2026 04:00 PM EasternExtended Trading$0.34 +0.00 (+0.79%) As of 07/2/2026 06:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Milestone Scientific Inc., a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. In addition, the company offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances, and disposable injection handpiece for the tactile control during the injection. Further, it provides CompuFlo Epidural, a computer-controlled anesthesia system for use in various medical applications. Additionally, the company offers company offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Roseland, New Jersey.InspireMD NYSE:NSPR$0.70 0.00 (0.00%) Closing price 07/2/2026 04:00 PM EasternExtended Trading$0.69 -0.01 (-1.72%) As of 07/2/2026 06:08 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.InspireMD, Inc., a medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard NPS, a non-invasive transcarotid artery revascularization device; as well as treating acute stroke with tandem lesions. InspireMD, Inc. has a strategic agreement with Jacobs Institute to execute an early feasibility study of CGuard Prime for the treatment of acute stroke patients with tandem lesions. The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.TELA Bio NASDAQ:TELA$0.72 0.00 (0.00%) Closing price 07/2/2026 04:00 PM EasternExtended Trading$0.72 0.00 (-0.19%) As of 07/2/2026 04:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Meta’s AI Compute Push Could Turn Its Massive CapEx Bill Into a Competitive Weapon Klarna’s Google Court Win Could Give Its BNPL Story a Needed Cash Catalyst SanDisk’s Volatility May Be Telling Bulls What They Want to Hear Why the Comcast Spin-Off Won't Fix What's Actually Broken Shorting the Grid: Bloom Energy’s $25B AI Power Play AST SpaceMobile’s Japan Catalyst Puts Its Rollout Story Back in Focus Why Kroger's Giant Eagle Deal Could Change Everything SMRs Spark a Chain Reaction for Nano Nuclear Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
